Literature DB >> 16537596

Plasmid DNA sequences present in conventional herpes simplex virus amplicon vectors cause rapid transgene silencing by forming inactive chromatin.

Masataka Suzuki1, Kazue Kasai, Yoshinaga Saeki.   

Abstract

The herpes simplex virus (HSV)-based amplicon vector, a bacterial-viral-mammalian cell shuttle system, holds promise as a versatile gene delivery vehicle because of its large transgene capacity. However, amplicon-mediated transgene expression is often transient. We hypothesized that the presence of prokaryotic DNA sequences within the packaged vector genome can trigger transcriptional silencing of the entire vector sequence. To test this, we constructed a novel amplicon vector devoid of bacterial sequences (minicircle [MC] amplicon). Although the same dose of the minicircle amplicon vector in normal human fibroblasts resulted in an expression of luciferase approximately 20 times higher than that caused by the conventional amplicon vector, no significant difference was observed in copy numbers of luciferase DNA between MC amplicon- and control-transduced cells. Quantitative analyses of levels of luciferase mRNA revealed that differential expression of luciferase was controlled at the transcriptional level. Chromatin immunoprecipitation PCR analyses of several regions of vector genomes revealed that the bacterial sequences found in the conventional amplicon DNA were associated with an inactive form of chromatin immediately after infection. The presence of bacterial sequences also affected the remaining vector sequences in the conventional amplicon vector. Finally, nude mice injected with the MC amplicon exhibited higher and more sustained expression of luciferase than those injected with the conventional amplicon, confirming the usefulness of the MC amplicon devoid of bacterial sequences. Although additional improvements are absolutely required, these findings are a significant first step toward developing a novel HSV amplicon vector that can achieve enhanced long-term transgene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16537596      PMCID: PMC1440389          DOI: 10.1128/JVI.80.7.3293-3300.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  Methylation-induced repression--belts, braces, and chromatin.

Authors:  A P Bird; A P Wolffe
Journal:  Cell       Date:  1999-11-24       Impact factor: 41.582

2.  The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo.

Authors:  Y Tan; S Li; B R Pitt; L Huang
Journal:  Hum Gene Ther       Date:  1999-09-01       Impact factor: 5.695

3.  The role of CpG motifs in innate immunity.

Authors:  A M Krieg
Journal:  Curr Opin Immunol       Date:  2000-02       Impact factor: 7.486

Review 4.  HSV-1 amplicon vectors--simplicity and versatility.

Authors:  M Sena-Esteves; Y Saeki; C Fraefel; X O Breakefield
Journal:  Mol Ther       Date:  2000-07       Impact factor: 11.454

Review 5.  Silencing of gene expression: implications for design of retrovirus vectors.

Authors:  D Pannell; J Ellis
Journal:  Rev Med Virol       Date:  2001 Jul-Aug       Impact factor: 6.989

6.  Single-step conversion of cells to retrovirus vector producers with herpes simplex virus-Epstein-Barr virus hybrid amplicons.

Authors:  M Sena-Esteves; Y Saeki; S M Camp; E A Chiocca; X O Breakefield
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver.

Authors:  Z Y Chen; S R Yant; C Y He; L Meuse; S Shen; M A Kay
Journal:  Mol Ther       Date:  2001-03       Impact factor: 11.454

8.  Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.

Authors:  Y Saeki; C Fraefel; T Ichikawa; X O Breakefield; E A Chiocca
Journal:  Mol Ther       Date:  2001-04       Impact factor: 11.454

9.  An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor.

Authors:  Hirokazu Kambara; Hideyuki Okano; E Antonio Chiocca; Yoshinaga Saeki
Journal:  Cancer Res       Date:  2005-04-01       Impact factor: 12.701

10.  Transitions in distinct histone H3 methylation patterns at the heterochromatin domain boundaries.

Authors:  C D Allis; S I Grewal
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

View more
  27 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

2.  Host cell detection of noncoding stuffer DNA contained in helper-dependent adenovirus vectors leads to epigenetic repression of transgene expression.

Authors:  P Joel Ross; Michael A Kennedy; Robin J Parks
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

3.  Analysis of human embryonic stem cells with regulatable expression of the cell adhesion molecule l1 in regeneration after spinal cord injury.

Authors:  Myungsik Yoo; Gunho Anthony Lee; Christopher Park; Rick I Cohen; Melitta Schachner
Journal:  J Neurotrauma       Date:  2014-03-15       Impact factor: 5.269

4.  Assembly of helper-dependent adenovirus DNA into chromatin promotes efficient gene expression.

Authors:  P Joel Ross; Michael A Kennedy; Carin Christou; Milagros Risco Quiroz; Kathy L Poulin; Robin J Parks
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

Review 5.  Targeting the central nervous system with herpes simplex virus / Sleeping Beauty hybrid amplicon vectors.

Authors:  Suresh de Silva; William J Bowers
Journal:  Curr Gene Ther       Date:  2011-10       Impact factor: 4.391

6.  Human gamma-satellite DNA maintains open chromatin structure and protects a transgene from epigenetic silencing.

Authors:  Jung-Hyun Kim; Thomas Ebersole; Natalay Kouprina; Vladimir N Noskov; Jun-Ichirou Ohzeki; Hiroshi Masumoto; Brankica Mravinac; Beth A Sullivan; Adam Pavlicek; Sinisa Dovat; Svetlana D Pack; Yoo-Wook Kwon; Patrick T Flanagan; Dmitri Loukinov; Victor Lobanenkov; Vladimir Larionov
Journal:  Genome Res       Date:  2009-01-13       Impact factor: 9.043

7.  Constitutive and Inducible Innate Responses in Cells Infected by HSV-1-Derived Amplicon Vectors.

Authors:  Eliza Tsitoura; Alberto L Epstein
Journal:  Open Virol J       Date:  2010-06-18

8.  Herpes simplex virus type 1/adeno-associated virus hybrid vectors.

Authors:  Anna Paula de Oliveira; Cornel Fraefel
Journal:  Open Virol J       Date:  2010-06-18

9.  Histone modifications associated with herpes simplex virus type 1 genomes during quiescence and following ICP0-mediated de-repression.

Authors:  Heather M Coleman; Viv Connor; Zara S C Cheng; Finn Grey; Chris M Preston; Stacey Efstathiou
Journal:  J Gen Virol       Date:  2008-01       Impact factor: 3.891

10.  Herpes Virus Amplicon Vectors.

Authors:  Suresh de Silva; William J Bowers
Journal:  Viruses       Date:  2009-12-01       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.